Related Experiment Videos
[Cardiovascular abnormalities in Bavaria 1984-1991]
A Schoetzau1, F van Santen, U Sauer
1Institut für Strahlenhygiene, Bundesamt für Strahlenschutz, Oberschleissheim/Neuherberg.
Summary
This study analyzed congenital heart defects in Bavarian livebirths from 1984-1991, finding a prevalence of 7.1 per 1000. The data highlights defect types, associated conditions, and a 12% fatality rate, offering crucial insights into pediatric cardiovascular health.
Area of Science:
- Pediatric Cardiology
- Developmental Biology
- Epidemiology
Background:
- Congenital heart defects (CHDs) are a significant cause of infant mortality.
- Understanding the prevalence and patterns of CHDs is crucial for public health initiatives.
- Previous studies have provided general data, but regional variations require specific investigation.
Purpose of the Study:
- To determine the birth prevalence and characteristics of structural congenital heart disease in Bavarian livebirths.
- To analyze the association of CHDs with chromosomal abnormalities, syndromes, and other malformations.
- To establish regional epidemiological data for Germany and compare findings with international studies.
Main Methods:
- Retrospective review of hospital records for livebirths in Bavaria between 1984 and 1991.
- Ascertainment of cases up to two years of age.
- Classification of cardiovascular malformations based on developmental mechanisms.
Main Results:
- Identified 7020 cases of structural CHD among 984,570 livebirths, with a birth prevalence of 7.1 per 1000 livebirths.
- Observed an increase in total prevalence from 5.9/1000 to 8.0/1000 between 1984 and 1991.
- Found that 78.1% of CHDs were isolated, while 21.9% were associated with other abnormalities; the overall fatality rate was 12.0%.
Conclusions:
- This study provides the first regional data on CHD birth prevalence in Germany.
- The classification scheme aids in categorizing CHD phenotypes into pathogenetic groups, potentially related to common causal factors.
- Findings underscore the importance of continued surveillance and research into the etiology and management of congenital heart defects.